Search - tctmd.com

Displaying 1 - 20 of 84

Sort: Relevancy | Date

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Shelley Wood

April 25, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Daily News

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Michael O'Riordan

March 01, 2023

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

Advertisement

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

ACC/AHA Release New Comprehensive ACS Guidelines

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

October 2023 News Roundup

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Many STEMI Patients Not Treated Within National Time Goals

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content